SCHEMBL24760902

SCHEMBL24760902

ClSN1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28844201 0.73 HIF1A (0.33)
SCHEMBL10865439 0.73 MGLL (0.44)
SCHEMBL16241323 0.69
SCHEMBL16749044 0.69
SCHEMBL4011856 0.69
SCHEMBL8507426 0.69
SCHEMBL6395961 0.69
SCHEMBL24724463 0.65
SCHEMBL23126257 0.63
SCHEMBL17058148 0.63 ADRB1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022157166-A1 THIAZOLOPYRIMIDONES AS INHIBITORS OF DDR1/2 AND THERAPEUTIC USES THEREOF Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) (ES) 2022-07-28 WO disclosed